Intestinal Permeability Score

You can feel fine and pass every item on a standard blood panel while your gut lining is quietly letting bacterial fragments slip into your bloodstream. This score is an attempt to catch that leak using markers your routine labs never look at.

It is an early, still-experimental read rather than a settled diagnosis. Knowing your baseline now gives you a personal number to track as this science matures.

What This Score Actually Measures

There is no single molecule called an intestinal permeability score. In blood, it is a composite built from several circulating markers that each capture a different part of gut-barrier trouble. Common ingredients include LBP (a protein that rises when bacterial fragments reach the blood), LPS (a piece of the outer coating of gut bacteria), and I-FABP (a protein spilled into blood when the cells lining the small intestine are injured). Some versions add zonulin, a protein thought to loosen the seals between gut-lining cells.

These markers are surrogates, not a direct measurement of how leaky your gut is. Of the blood ingredients, LBP has the best support: it tracked with the classic sugar-based permeability test across several groups of adults, independent of age, body weight, and sex. Zonulin should be read with more caution, because widely used commercial zonulin blood tests have been shown to also pick up related proteins rather than zonulin alone, which muddies how much a given result really reflects barrier leak. The markers each reflect slightly different biology, which is exactly why a combined score tends to be more informative than any single number.

Because the assays are not yet standardized and no agreed clinical cutoff exists, this is best treated as a research and early-detection tool. A single reading is a starting point for a conversation, not a verdict.

Type 2 Diabetes

The clearest evidence for an actual blood permeability score comes from diabetes research. In a single cross-sectional study of 291 adults (130 with type 2 diabetes and 161 without), a derived score built from circulating LPS, LBP, and I-FABP ran roughly 24% higher in people with type 2 diabetes than in those without it, and the individual markers LBP and I-FABP were higher too.

People in the top third of that score were about 5 times as likely to have type 2 diabetes (5.07 times, confidence interval 1.72 to 14.95) after accounting for age, sex, and body weight. Adding the score to a standard clinical model only nudged prediction upward (the model's accuracy rose from 0.954 to 0.962, a trend that did not reach statistical significance), and because this was a snapshot in time it cannot prove the leak came first. Still, it is the most on-target signal that a blood permeability composite tracks metabolic disease.

Fatty Liver and Metabolic Health

Gut leak and metabolic strain travel together. A meta-analysis found that intestinal permeability is increased in people with non-alcoholic fatty liver disease (NAFLD, fat buildup in the liver not caused by alcohol) and rises with the severity of liver fat. Reviews describe children with fatty liver carrying higher LBP and higher circulating bacterial endotoxin than peers, though the exact size of that gap is not firmly established.

In overweight pregnancy, higher blood zonulin lined up with more inflammation, higher insulin resistance, and higher triglycerides, and in obesity studies permeability markers rose alongside waist size and metabolic risk. The recurring theme is that a leaky barrier appears to feed low-level inflammation from bacterial fragments, which in turn strains the liver and blood sugar control.

Heart and Blood Vessel Disease

A meta-analysis of cardiovascular disease found that blood and stool permeability markers, including LPS, zonulin, LBP, and I-FABP, were substantially higher in affected patients than in controls, and prospective studies have linked higher zonulin and LBP to later cardiovascular mortality. In people with newly diagnosed atrial fibrillation (an irregular heartbeat), higher LPS was more common in those who went on to have a major cardiovascular event, and it tracked with signs of structural remodeling in the heart.

Separate studies link a leaky gut to high blood pressure, where the tight-junction protein zonulin was reported to be markedly elevated. None of this makes the score a heart test, but it places gut-barrier leak among the low-grade inflammatory pressures that push cardiovascular risk over time.

Brain, Mood, and Immune Conditions

Barrier markers show up across neuroimmune conditions. In multiple sclerosis, higher blood zonulin predicted disease progression over the following year and mirrored breakdown of the barrier protecting the brain. Adolescents with major depression had higher plasma zonulin, I-FABP, and LPS than healthy peers, and elevations appear in schizophrenia-spectrum and chronic fatigue research as well.

The signal is real but uneven. In depression specifically, reviews describe inconsistent results, and some studies even found certain markers lower rather than higher, which is why researchers increasingly argue these should be interpreted as a nuanced panel rather than one interchangeable readout.

Why Lower Is Not Always Better

It is tempting to read the score as a simple good-number bad-number scale, but the biology resists that. Most of the time, higher markers mean more leak and more bacterial products reaching the blood. Yet in some severe intestinal diseases and after certain drug treatments, markers such as zonulin can fall, not because the barrier healed but because the cells that produce them were depleted or because the body mounted a compensatory repair response. This is a phenotype indicator with several moving parts, so an unexpected low value deserves interpretation in context rather than reflexive reassurance.

Why One Reading Is Not Enough

This marker rewards tracking over time far more than any single snapshot. The blood ingredients differ in how stable they are: under standardized conditions, plasma LBP and zonulin were highly reproducible across repeated draws, while functional permeability tests varied much more. That means a lone value can be thrown off by what you ate, a recent workout, or a passing illness, but a trend line filters out that noise.

Get a baseline, and if you are making gut-focused changes, retest in about 3 to 6 months to see whether your numbers are actually moving, then at least once a year. Because LBP behaves like an inflammation-responsive protein and can rise for reasons unrelated to the gut, confirming an unexpected result with a repeat draw under similar conditions is prudent before drawing conclusions.

When Results Can Be Misleading

Several everyday factors can distort a single reading without reflecting your true gut health:

• Recent hard exercise: a single run raised I-FABP to nearly twice its resting level (about 191% of the pre-exercise value) and sharply increased permeability, then normalized. Avoid intense exercise in the day or two before testing.
• Acute illness or inflammation: LBP rises as part of the general inflammatory response, so a recent infection or injury can push the score up even when your gut is fine.
• Pre-test diet: high-fat meals increase permeability short-term, and food residue can interfere with some permeability testing, so standardized fasting conditions matter.
• Age, sex, and body weight: these shift several markers, which is part of why no universal cutoff has been agreed on.

What To Do With an Out-of-Pattern Result

A single high score is a prompt to investigate, not to self-diagnose leaky gut. Repeat the test under standardized conditions first. Then read it alongside companion markers: hs-CRP (a sensitive blood marker of body-wide inflammation) and stool calprotectin (a marker of gut inflammation) help clarify whether the leak is paired with active inflammation, and a metabolic panel connects it to blood sugar and liver signals.

If you have gastrointestinal symptoms, blood in the stool, unexplained weight loss, or a family history of inflammatory bowel disease, a gastroenterologist can pursue functional or structural testing, including the urine-based sugar permeability test that measures barrier function more directly. The pattern that warrants action is a persistently elevated score combined with symptoms or other abnormal markers, rather than one isolated number in an otherwise well person.